NLM Logo

MEP regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
MEP regimen
Unique ID
C110661
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C110661
Entry Term(s)
ME cisplatin
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Epirubicin
Mitomycin
Frequency
1
Note
a chemotherapy regimen consisting of above Cisplatin, Epirubicin & Mitomycin; used for treatment of carcinoma of unknown primary origin
Source
Oncology 1998 Mar-Apr;55(2):116-21
Date of Entry
1998/03/06
Revision Date
2003/01/16
MEP regimen Preferred
page delivered in 0.005s